Evidence map›Paper›PMID 33042048›Full record

ArticleFrontiers in microbiology2020

Characterization of a New Transposon, Tn

Qichao Chen, Yanfeng Lin, Zhonghong Li, Lanfen Lu, Peihan Li, Kaiying Wang, Lang Yang, Hui Ma, Peng Li, Hongbin Song

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Coexistence of plasmid-mediatedMicrobiology spectrum · 2024
    Article
  2. The emergence of carbapenemase-producingFrontiers in public health · 2023
    Article
  3. Article
  4. Coexistence ofMicrobiology spectrum · 2022
    Article
  5. Molecular characterization of NDM-1-producing carbapenem-resistantFrontiers in cellular and infection microbiology · 2022
    Article
  6. Emergence of a Carbapenem-ResistantFrontiers in microbiology · 2022
    Article
  7. Article
  8. Co-occurrence ofFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Qichao ChenCenter for Disease Control and Prevention of People's Liberation Army, Beijing, China.
Yanfeng LinCenter for Disease Control and Prevention of People's Liberation Army, Beijing, China.
Zhonghong LiCenter for Disease Control and Prevention of People's Liberation Army, Beijing, China.
Lanfen LuDepartment of Laboratory Diagnosis, Sun Yat-sen University Affiliated Zhongshan Hospital, Zhongshan, China.
Peihan LiCenter for Disease Control and Prevention of People's Liberation Army, Beijing, China.
Kaiying WangCenter for Disease Control and Prevention of People's Liberation Army, Beijing, China.
Lang YangCenter for Disease Control and Prevention of People's Liberation Army, Beijing, China.
Hui MaThe Sixth Medical Center of People's Liberation Army General Hospital, Beijing, China.
Peng LiCenter for Disease Control and Prevention of People's Liberation Army, Beijing, China.
Hongbin SongCenter for Disease Control and Prevention of People's Liberation Army, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsA multidrug-resistant

resultsStrain CBG15936 belongs to ST932 and is resistant to carbapenems. The

conclusionA new transposon, Tn

Indexed as

blaNDM1carbapenem resistanceEnterobacter cloacaeTn6696whole genome sequencing

Identifiers

PMID33042048
PMCPMC7522282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.